Members of Kibbutz Hanita are suing the Chinese-controlled Ballet Vision fund for refusing to buy their remaining stake in an intraocular lens plant, citing losses and what it says is a Chinese government ban on new investments in Israel since the war

Members of Kibbutz Hanita near Israel’s northern border are demanding $11 million from Ballet Vision, the Chinese fund that controls 80% of the Hanita Lenses plant, accusing it of refusing to exercise an option to purchase the kibbutz’s remaining shares, according to a lawsuit filed in Tel Aviv District Court.

In a response letter attached to the lawsuit, the Chinese fund said that since the outbreak of the war in Israel, Beijing has classified Israel as a “high-risk area” and imposed a ban on any new Chinese investments in the country, making it impossible to carry out the option.

According to the lawsuit, in 2021 the kibbutz sold 74% of Hanita Lenses, which manufactures intraocular lenses for medical use, to Ballet Vision for $35 million. Of that sum, $25 million was paid to kibbutz members, with an additional $10 million injected into the company.

    • Cowbee [he/they]@lemmy.ml
      2·
      2 hours ago

      I answered every single one of your claims, fully, and with evidence. What issues did I sidestep? Which of my claims are “propaganda?” You’re sidestepping the entire argument itself because you can’t make one, so you jump to insults to protect your honor.